Literature DB >> 15933865

[Antimicrobially effective compounded medications. Clinical value and critical comments].

R Eifler-Bollen1, J W Fluhr.   

Abstract

Triphenyl-methan dyes, traditionally used in dermatology should be reevaluated with caution. Their use should be limited due to the uncertain pharmacological-toxicological risk-benefit ratio and the lack of pharmacological quality of the raw substances. Sometimes antimicrobial activity is insufficient and the cytotoxic effects, along with the inhibition of wound healing, make these dyes less suitable for topical treatment in dermatology. Chinolinolsulfat (Chinosol) and Clioquinol should be used in low concentrations and only on small areas. Due to their negative benefit-risk profile ethracidinlactate-monohydrate (Rivanol) and phenylmercuri-borate (Mercuchrom) should not be used as topical antimicrobial substances. The present publication is intended to give practical recommendations on compounded medications for topical antimicrobial use. Even though some of the cited compounds must be considered critically, we recommend the topical use of chlorhexidine salts, polihexanide, triclosan, polyvidone iodide and silver compounds. Useful standardised compounded formulations containing these four groups are listed in the NRF (Neues Rezeptur Formularium: New German Pharmacopoeia for compounded medication).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933865     DOI: 10.1007/s00105-005-0974-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

Review 1.  [Topical antibiotics and antiseptics. Agents, spectrum, adverse effects].

Authors:  P H Höger
Journal:  Hautarzt       Date:  1998-04       Impact factor: 0.751

2.  Use of antimicrobial agents in consumer products.

Authors:  Litjen Tan; Nancy H Nielsen; Donald C Young; Zoltan Trizna
Journal:  Arch Dermatol       Date:  2002-08

Review 3.  [Local therapy of the poorly healing wound].

Authors:  R Niedner
Journal:  Med Monatsschr Pharm       Date:  1990-11

Review 4.  Toxicological aspects of topical silver pharmaceuticals.

Authors:  M A Hollinger
Journal:  Crit Rev Toxicol       Date:  1996-05       Impact factor: 5.635

5.  [Triclosan, a topical dermatologic agent. In vitro- and in vivo studies on the effectiveness of a new preparation in the New German Formulary].

Authors:  M Gloor; A Becker; B Wasik; E Kniehl
Journal:  Hautarzt       Date:  2002-11       Impact factor: 0.751

6.  [Prescription formulations with clioquinol].

Authors:  H Ippen
Journal:  Hautarzt       Date:  1995-12       Impact factor: 0.751

7.  [Chemical carcinogens and their relevance for cancer induction in man with special reference to dermatological problems (author's transl)].

Authors:  D Schmähl; B Bertram
Journal:  Derm Beruf Umwelt       Date:  1981

8.  Triclosan: applications and safety.

Authors:  H N Bhargava; P A Leonard
Journal:  Am J Infect Control       Date:  1996-06       Impact factor: 2.918

9.  Generalized argyria after habitual use of AgNO3.

Authors:  S M Lee; S H Lee
Journal:  J Dermatol       Date:  1994-01       Impact factor: 4.005

Review 10.  Antiseptics and disinfectants: activity, action, and resistance.

Authors:  G McDonnell; A D Russell
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.